United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 29, 2026 · Filed Jun 30, 2026

On Jun 29, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$545.80 for US$5.19M under a trading plan, leaving 40,513 shares. Filed Jun 30, 2026 (Form 4).

Sold
9,500 shares
Price
US$545.80 average (US$539.98 to US$548.96)
Value
US$5.19M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 29, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jun 29, 2026Common StockSale120US$539.9849,893Direct
Jun 29, 2026Common StockSale360US$541.2449,533Direct
Jun 29, 2026Common StockSale80US$541.8649,453Direct
Jun 29, 2026Common StockSale585US$543.3748,868Direct
Jun 29, 2026Common StockSale1,594US$544.4047,274Direct
Jun 29, 2026Common StockSale2,165US$545.3045,109Direct
Jun 29, 2026Common StockSale1,705US$546.2843,404Direct
Jun 29, 2026Common StockSale759US$547.1242,645Direct
Jun 29, 2026Common StockSale1,702US$548.2940,943Direct
Jun 29, 2026Common StockSale430US$548.9640,513Direct

Source

View original at SEC

Related